Featured on The Wall Street Journal: Biotech Company Uses Machine Learning to Find Coronavirus Therapies

“AbCellera Biologics Inc., a Canadian biotechnology startup that uses machine learning to develop antibody therapies, finds itself on the front lines of the Covid-19 global pandemic.”

Read full coverage on The Wall Street Journal.

PARTNERSHIP

Together we can make game-changing discoveries.